STAAR Surgical Sees Unusually Large Options Volume (NASDAQ:STAA)

09 Dec 2025, 11:12 by Scott Moore · The Cerbat Gem

STAAR Surgical Company (NASDAQ:STAA – Get Free Report) was the target of some unusual options trading activity on Tuesday. Investors acquired 5,565 put options on the company. This represents an increase of 401% compared to the average volume of 1,111 put options.

Analysts Set New Price Targets

A number of brokerages have issued reports on STAA. Piper Sandler reaffirmed a “neutral” rating on shares of STAAR Surgical in a report on Monday, October 27th. Canaccord Genuity Group reiterated a “hold” rating and issued a $28.00 price objective on shares of STAAR Surgical in a report on Tuesday, October 21st. Finally, Weiss Ratings restated a “sell (d)” rating on shares of STAAR Surgical in a research note on Wednesday, October 8th. Ten analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, STAAR Surgical currently has an average rating of “Reduce” and a consensus target price of $20.67.

Check Out Our Latest Analysis on STAAR Surgical

Insider Activity

In other news, major shareholder Broadwood Partners, L.P. bought 797,486 shares of the stock in a transaction that occurred on Friday, November 21st. The stock was purchased at an average price of $27.86 per share, for a total transaction of $22,217,959.96. Following the completion of the purchase, the insider owned 15,019,491 shares in the company, valued at approximately $418,443,019.26. This trade represents a 5.61% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Over the last three months, insiders have acquired 1,500,000 shares of company stock worth $41,061,615. 0.59% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in STAA. CWM LLC increased its position in STAAR Surgical by 74.1% during the second quarter. CWM LLC now owns 1,563 shares of the medical instruments supplier’s stock worth $26,000 after buying an additional 665 shares during the period. Caitong International Asset Management Co. Ltd grew its position in shares of STAAR Surgical by 2,605.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,055 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 1,016 shares during the last quarter. US Bancorp DE grew its position in shares of STAAR Surgical by 1,693.0% during the first quarter. US Bancorp DE now owns 2,044 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 1,930 shares during the last quarter. Brooklyn Investment Group increased its holdings in shares of STAAR Surgical by 1,564.0% in the 1st quarter. Brooklyn Investment Group now owns 2,679 shares of the medical instruments supplier’s stock valued at $47,000 after acquiring an additional 2,518 shares during the period. Finally, GAMMA Investing LLC raised its position in STAAR Surgical by 61.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,856 shares of the medical instruments supplier’s stock valued at $50,000 after purchasing an additional 706 shares during the last quarter. Hedge funds and other institutional investors own 96.70% of the company’s stock.

STAAR Surgical Stock Performance

NASDAQ STAA traded up $2.97 during trading hours on Tuesday, hitting $26.51. The company had a trading volume of 4,027,705 shares, compared to its average volume of 1,155,368. The business has a 50 day moving average of $26.32 and a 200-day moving average of $23.44. The company has a market cap of $1.32 billion, a PE ratio of -13.62 and a beta of 1.01. STAAR Surgical has a 1-year low of $13.50 and a 1-year high of $30.81.

About STAAR Surgical

(Get Free Report)